FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
E-4177, 135070-05-2, E-4177 Intermediate 7148-03-0, stock 647g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
E-4177, 135070-05-2, E-4177 Intermediate 114772-34-8, stock 513.7g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
E-4177, 135070-05-2, E-4177 Intermediate 114772-38-2, stock 643.1g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
E-4177, 135070-05-2, E-4177 Intermediate 135070-80-3, stock 333.8g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
E-4177, 135070-05-2, E-4177 Intermediate 135071-34-0, stock 458.8g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
E-4177, 135070-05-2, E-4177 Intermediate 53929-59-2, stock 996.8g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
E-4177, 135070-05-2, E-4177 Intermediate 1759-53-1, stock 729.1g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
E-4177, 135070-05-2, E-4177 Intermediate , stock 518.6g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |